Entry |
|
Name |
Eganelisib (USAN) |
Formula |
C30H24N8O2
|
Exact mass |
528.2022
|
Mol weight |
528.56
|
Structure |

|
Class |
Antineoplastic
DG03139 PI3K inhibitor
|
Efficacy |
Antineoplastic, Phosphatidylinositol 3-kinase inhibitor |
Target |
|
Pathway |
|
Brite |
Drug groups [BR:br08330]
Antineoplastic
DG03139 PI3K inhibitor
D11896 Eganelisib
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Phosphotransferase
PIK3CG
D11896 Eganelisib (USAN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 40
1 N1b N 19.3200 -24.5000
2 C1c C 18.1300 -23.8000
3 C8y C 18.1300 -22.4000
4 N4y N 16.9400 -21.7000
5 C8y C 16.9400 -20.3000
6 C8y C 18.2000 -19.6000
7 C8y C 19.3900 -20.3000
8 C8x C 19.3900 -21.7000
9 C1a C 16.8700 -24.4300
10 C8y C 18.2000 -18.2000
11 C8x C 19.3900 -17.5000
12 C8x C 20.5800 -18.2000
13 C8x C 20.5800 -19.6000
14 C3b C 17.0100 -17.5000
15 C3b C 15.8200 -16.8000
16 C8y C 14.6300 -16.1000
17 C8x C 13.3700 -16.5900
18 N5x N 12.3900 -15.5400
19 N4y N 13.0900 -14.2800
20 C8x C 14.4900 -14.7000
21 C1a C 12.5300 -13.0200
22 O5x O 15.7500 -19.5300
23 C8y C 15.6800 -22.3300
24 C8x C 15.6800 -23.7300
25 C8x C 14.4900 -24.4300
26 C8x C 13.3000 -23.6600
27 C8x C 13.3000 -22.2600
28 C8x C 14.4900 -21.6300
29 C5a C 19.3200 -25.9000
30 C8y C 20.5100 -26.6000
31 O5a O 18.1300 -26.6000
32 C8y C 20.9300 -27.9300
33 N4y N 22.3300 -27.9300
34 N5x N 22.8200 -26.6000
35 C8y C 21.7000 -25.7600
36 N5x N 20.2300 -29.1200
37 C8x C 20.9300 -30.3800
38 C8x C 22.3300 -30.3800
39 C8x C 23.0300 -29.1900
40 N1a N 21.7000 -24.3600
BOND 45
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 6 7 1
7 7 8 1
8 3 8 2
9 2 9 1 #Up
10 6 10 2
11 10 11 1
12 11 12 2
13 12 13 1
14 7 13 2
15 10 14 1
16 14 15 3
17 15 16 1
18 16 17 1
19 17 18 2
20 18 19 1
21 19 20 1
22 16 20 2
23 19 21 1
24 5 22 2
25 4 23 1
26 23 24 2
27 24 25 1
28 25 26 2
29 26 27 1
30 27 28 2
31 23 28 1
32 29 30 1
33 29 31 2
34 29 1 1
35 30 32 2
36 32 33 1
37 33 34 1
38 34 35 2
39 30 35 1
40 32 36 1
41 36 37 2
42 37 38 1
43 38 39 2
44 33 39 1
45 35 40 1
|